Literature DB >> 25659235

Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota.

C John Michet1, Katerina Strobova2, Sara Achenbach3, Cynthia S Crowson4, Eric L Matteson5.   

Abstract

OBJECTIVE: To examine whether all-cause hospitalization rates for patients with rheumatoid arthritis (RA) differ from those for patients without RA. PATIENTS AND METHODS: This was a retrospective population-based cohort study focused on Olmsted County, Minnesota. The RA cohort consisted of patients 18 years and older who first fulfilled 1987 American College of Rheumatology criteria for RA in the 1980 to 2007 period, and was compared with a cohort of similar age, sex, and calendar year without RA. Data on all hospitalizations were retrieved electronically for the 1987 to 2012 period. Analyses used person-year methods and rate ratios (RRs) comparing patients with and without RA.
RESULTS: The 799 patients with RA experienced 2968 hospitalizations, and the 797 patients without RA experienced 2069 hospitalizations. Patients with RA were hospitalized at a greater rate than were patients without RA (RR, 1.51; 95% CI, 1.42-1.59). This increased rate of hospitalization was found in both sexes, all age groups, all calendar years studied, and throughout disease duration. Men with RA were hospitalized for depression at a greater rate than were men without RA (RR, 7.16; 95% CI, 2.78-30.67). Patients with RA were hospitalized at a greater rate for diabetes mellitus than were subjects without RA (RR, 2.45; 95% CI, 1.34-4.89). In patients with RA, the indicators of disease severity (eg, seropositivity, erosions, and nodules) in the first year after RA incidence were associated with higher rates of hospitalization.
CONCLUSION: Patients with RA were hospitalized for all causes at a greater rate than were patients without RA. Increased rates of hospitalization were true for several disease categories and patient subgroups.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25659235      PMCID: PMC4334562          DOI: 10.1016/j.mayocp.2014.12.009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

3.  Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality.

Authors:  Courtney A Shourt; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

4.  Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.

Authors:  T Pincus; T Sokka; C P Chung; G Cawkwell
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

5.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

Review 6.  Comorbidities in rheumatoid arthritis.

Authors:  Kaleb Michaud; Frederick Wolfe
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-10       Impact factor: 4.098

7.  Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Michael P Lavalley
Journal:  Arthritis Rheum       Date:  2008-04-15

8.  Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

Authors:  Michele F Doran; Cynthia S Crowson; Gregory R Pond; W Michael O'Fallon; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2002-09

9.  Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.

Authors:  Sherine E Gabriel; Cynthia S Crowson; Hilal Maradit Kremers; Michele F Doran; Carl Turesson; W Michael O'Fallon; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2003-01

Review 10.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

View more
  10 in total

1.  Hospitalizations Associated With Rheumatic Disease in Alaska, 2015-2018.

Authors:  Elizabeth D Ferucci; Peter Holck
Journal:  ACR Open Rheumatol       Date:  2022-03-19

2.  Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.

Authors:  José M Lezcano-Valverde; Fernando Salazar; Leticia León; Esther Toledano; Juan A Jover; Benjamín Fernandez-Gutierrez; Eduardo Soudah; Isidoro González-Álvaro; Lydia Abasolo; Luis Rodriguez-Rodriguez
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

3.  Relationship between daily pain and affect in women with rheumatoid arthritis: lower optimism as a vulnerability factor.

Authors:  Zuzanna Kwissa-Gajewska; Ewa Gruszczyńska
Journal:  J Behav Med       Date:  2017-07-17

4.  Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016.

Authors:  Gabriel Maciel; Luisa Servioli; Carlotta Nannini; Alvise Berti; Cynthia S Crowson; Sara J Achenbach; Eric L Matteson; Divi Cornec
Journal:  RMD Open       Date:  2018-02-28

5.  Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population-Based Study.

Authors:  Carol A Hitchon; Randy Walld; Christine A Peschken; Charles N Bernstein; James M Bolton; Renée El-Gabalawy; John D Fisk; Alan Katz; Lisa M Lix; James Marriott; Scott B Patten; Jitender Sareen; Alexander Singer; Ruth Ann Marrie
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-01       Impact factor: 4.794

6.  Rheumatoid Arthritis in Silica-Exposed Workers.

Authors:  Young-Sun Min; Min-Gi Kim; Yeon-Soon Ahn
Journal:  Int J Environ Res Public Health       Date:  2021-12-03       Impact factor: 3.390

7.  Prevalence of hospital readmissions and related factors in patients with autoimmune diseases.

Authors:  Tatiana Morales-Tisnés; Lina Quintero-Ortiz; Elías Quintero-Muñoz; Fabio Sierra-Matamoros; Julián Arias-Aponte; Adriana Rojas-Villarraga
Journal:  J Transl Autoimmun       Date:  2021-09-08

8.  Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results.

Authors:  Pedro Santos-Moreno; Paola Castillo; Laura Villareal; Carlos Pineda; Hugo Sandoval; Omaira Valencia
Journal:  Open Access Rheumatol       Date:  2020-11-06

9.  Trends in Hospitalization Rates, Major Causes of Hospitalization, and In-Hospital Mortality in Rheumatoid Arthritis in the United States From 2000 to 2014.

Authors:  Priyanka Iyer; Yubo Gao; Elizabeth H Field; Jeffrey R Curtis; Charles F Lynch; Mary Vaughan-Sarrazin; Namrata Singh
Journal:  ACR Open Rheumatol       Date:  2020-11-20

Review 10.  Interleukin 27 Signaling in Rheumatoid Arthritis Patients: Good or Evil?

Authors:  Liang Han; Zhe Chen; Kun Yu; Jiahui Yan; Tingting Li; Xin Ba; Weiji Lin; Yao Huang; Pan Shen; Ying Huang; Kai Qin; Yinhong Geng; Yafei Liu; Yu Wang; Shenghao Tu
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.